Caloric Restriction Mimetics Enhance Anticancer Immunosurveillance

Cancer Cell

Volumn 30, Issue 1, 2016, Pages 147-160

  Pietrocola, Federico ^a,b,c   Pol, Jonathan ^a,b,c,e   Vacchelli, Erika ^a,b,c   Rao, Shuan ^f   Enot, David P ^a,g   Baracco, Elisa E ^a,b,c,d   Levesque, Sarah ^a,b,c,d   Castoldi, Francesca ^a,b,c,d,h   Jacquelot, Nicolas ^a,d,i   Yamazaki, Takahiro ^a,d,i   Senovilla, Laura ^a,b,c,e   Marino, Guillermo ^a,b,c   Aranda, Fernando ^a,b,c   Durand, Sylvère ^a,g   Sica, Valentina ^a,b,c,d   Chery, Alexis ^a,g   Lachkar, Sylvie ^a,b,c,d   Sigl, Verena ^f   Bloy, Norma ^a,b,c,d   Buque, Aitziber ^a,b,c,d   Falzoni, Simonetta ^j   Ryffel, Bernhard ^k,l   Apetoh, Lionel ^m,n,o   Di Virgilio, Francesco ^j   Madeo, Frank ^p,q   Maiuri, Maria Chiara ^a,b,c,d   Zitvogel, Laurence ^a,d,i   Levine, Beth ^r   Penninger, Josef M ^f   Kroemer, Guido ^{a,b,c,e,g,s,t}   more..

^a U1138 ^*

^b INSERM   (France)

^c CENTRE DE RECHERCHE DES CORDELIERS   (France)

^d UNIVERSITÉ PARIS SACLAY   (France)

^e UNIVERSITÉ PARIS DESCARTES   (France)

^f INSTITUTE OF MOLECULAR BIOTECHNOLOGY   (Austria)

^g Metabolomics and Cell Biology Platforms   (France)

^h Sotio as   (Czech Republic)

ⁱ Center of Clinical Investigations in Biotherapies of Cancer (CICBT) 507   (France)

^j UNIVERSITY OF FERRARA   (Italy)

^k UNIVERSITÉ D'ORLÉANS   (France)

^l UNIVERSITY OF CAPE TOWN   (South Africa)

^m Chu   (France)

ⁿ UNIVERSITÉ DE BOURGOGNE   (France)

^o CENTRE GEORGES FRANÇOIS LECLERC   (France)

^p UNIVERSITY OF GRAZ   (Austria)

^q BIOTECHMED GRAZ   (Austria)

^r UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^s HÔPITAL EUROPÉEN GEORGES POMPIDOU   (France)

^t KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

more..

Author keywords

cancer; chemotherapy; immunosurveillance; regulatory T cell

Indexed keywords

ADENOSINE TRIPHOSPHATE CITRATE SYNTHASE; CALORIC RESTRICTION MIMETIC AGENT; CELL PROTEIN; CISPLATIN; HYDROXYCITRIC ACID; LYSINE; MITOXANTRONE; NUTRACEUTICAL; OXALIPLATIN; SPERMIDINE; UNCLASSIFIED DRUG; ATG5 PROTEIN, MOUSE; AUTOPHAGY RELATED PROTEIN 5; CITRIC ACID; KRAS2 PROTEIN, MOUSE; METHOTREXATE; PROTEIN P21;

ACETYLATION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOPHAGY; CALORIC RESTRICTION; CANCER CHEMOTHERAPY; CANCER INHIBITION; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; IMMUNOSURVEILLANCE; IN VIVO STUDY; LUNG CANCER; MOUSE; NONHUMAN; ONCOGENE K RAS; PRIORITY JOURNAL; PROTEIN ACETYLATION; REGULATORY T LYMPHOCYTE; TUMOR IMMUNITY; ANIMAL; CANCER TRANSPLANTATION; DIET THERAPY; DRUG EFFECTS; GENETICS; HUMAN; IMMUNOLOGICAL MONITORING; IMMUNOLOGY; MUTATION; NEOPLASMS, EXPERIMENTAL; PROCEDURES; TUMOR CELL LINE;

ANIMALS; AUTOPHAGY; AUTOPHAGY-RELATED PROTEIN 5; CALORIC RESTRICTION; CELL LINE, TUMOR; CITRATES; HUMANS; METHOTREXATE; MICE; MONITORING, IMMUNOLOGIC; MUTATION; NEOPLASM TRANSPLANTATION; NEOPLASMS, EXPERIMENTAL; PROTO-ONCOGENE PROTEINS P21(RAS); SPERMIDINE; T-LYMPHOCYTES, REGULATORY;

EID: 84979780741     PISSN: 15356108     EISSN: 18783686     Source Type: Journal    
DOI: 10.1016/j.ccell.2016.05.016     Document Type: Article

References (52)

1. Bindea, G., Mlecnik, B., Tosolini, M., Kirilovsky, A., Waldner, M., Obenauf, A.C., Angell, H., Fredriksen, T., Lafontaine, L., Berger, A., et al. Spatiotemporal dynamics of intratumoral immune cells reveal the immune landscape in human cancer. Immunity 39 (2013), 782–795.
2. Casagrande, D.S., Rosa, D.D., Umpierre, D., Sarmento, R.A., Rodrigues, C.G., Schaan, B.D., Incidence of cancer following bariatric surgery: systematic review and meta-analysis. Obes. Surg. 24 (2014), 1499–1509.
3. Cheng, C.W., Adams, G.B., Perin, L., Wei, M., Zhou, X., Lam, B.S., Da Sacco, S., Mirisola, M., Quinn, D.I., Dorff, T.B., et al. Prolonged fasting reduces IGF-1/PKA to promote hematopoietic-stem-cell-based regeneration and reverse immunosuppression. Cell Stem Cell 14 (2014), 810–823.
4. Chuah, L.O., Yeap, S.K., Ho, W.Y., Beh, B.K., Alitheen, N.B., In vitro and in vivo toxicity of garcinia or hydroxycitric acid: a review. Evid. Based Complement. Alternat. Med., 2012, 2012, 197920.
5. Demidenko, E., The assessment of tumour response to treatment. J. R. Stat. Soc. Ser. C 55 (2006), 365–377.
6. Eisenberg, T., Knauer, H., Schauer, A., Buttner, S., Ruckenstuhl, C., Carmona-Gutierrez, D., Ring, J., Schroeder, S., Magnes, C., Antonacci, L., et al. Induction of autophagy by spermidine promotes longevity. Nat. Cell Biol. 11 (2009), 1305–1314.
7. Galluzzi, L., Buque, A., Kepp, O., Zitvogel, L., Kroemer, G., Immunological effects of conventional chemotherapy and targeted anticancer agents. Cancer Cell 28 (2015), 690–714.
8. Galluzzi, L., Pietrocola, F., Bravo-San Pedro, J.M., Amaravadi, R.K., Baehrecke, E.H., Cecconi, F., Codogno, P., Debnath, J., Gewirtz, D.A., Karantza, V., et al. Autophagy in malignant transformation and cancer progression. EMBO J. 34 (2015), 856–880.
9. Gilbert, C.A., Slingerland, J.M., Cytokines, obesity, and cancer: new insights on mechanisms linking obesity to cancer risk and progression. Annu. Rev. Med. 64 (2013), 45–57.
10. Guo, J.Y., Xia, B., White, E., Autophagy-mediated tumor promotion. Cell 155 (2013), 1216–1219.
11. Harrison, D.E., Strong, R., Sharp, Z.D., Nelson, J.F., Astle, C.M., Flurkey, K., Nadon, N.L., Wilkinson, J.E., Frenkel, K., Carter, C.S., et al. Rapamycin fed late in life extends lifespan in genetically heterogeneous mice. Nature 460 (2009), 392–395.
12. Jiang, P., Mizushima, N., Autophagy and human diseases. Cell Res 24 (2014), 69–79.
13. Kalaany, N.Y., Sabatini, D.M., Tumours with PI3K activation are resistant to dietary restriction. Nature 458 (2009), 725–731.
14. Kepp, O., Senovilla, L., Kroemer, G., Immunogenic cell death inducers as anticancer agents. Oncotarget 5 (2014), 5190–5191.
15. Kibe, R., Kurihara, S., Sakai, Y., Suzuki, H., Ooga, T., Sawaki, E., Muramatsu, K., Nakamura, A., Yamashita, A., Kitada, Y., et al. Upregulation of colonic luminal polyamines produced by intestinal microbiota delays senescence in mice. Sci. Rep., 4, 2014, 4548.
16. Klionsky, D.J., Abdalla, F.C., Abeliovich, H., Abraham, R.T., Acevedo-Arozena, A., Adeli, K., Agholme, L., Agnello, M., Agostinis, P., Aguirre-Ghiso, J.A., et al. Guidelines for the use and interpretation of assays for monitoring autophagy. Autophagy 8 (2012), 445–544.
17. Ko, A., Kanehisa, A., Martins, I., Senovilla, L., Chargari, C., Dugue, D., Marino, G., Kepp, O., Michaud, M., Perfettini, J.L., et al. Autophagy inhibition radiosensitizes in vitro, yet reduces radioresponses in vivo due to deficient immunogenic signalling. Cell Death Differ. 21 (2014), 92–99.
18. Lahl, K., Loddenkemper, C., Drouin, C., Freyer, J., Arnason, J., Eberl, G., Hamann, A., Wagner, H., Huehn, J., Sparwasser, T., Selective depletion of Foxp3+ regulatory T cells induces a scurfy-like disease. J. Exp. Med. 204 (2007), 57–63.
19. Lee, C., Longo, V.D., Fasting vs dietary restriction in cellular protection and cancer treatment: from model organisms to patients. Oncogene 30 (2011), 3305–3316.
20. Lee, C., Raffaghello, L., Brandhorst, S., Safdie, F.M., Bianchi, G., Martin-Montalvo, A., Pistoia, V., Wei, M., Hwang, S., Merlino, A., et al. Fasting cycles retard growth of tumors and sensitize a range of cancer cell types to chemotherapy. Sci. Transl Med., 4, 2012, 124ra127.
21. Levine, B.L., June, C.H., Perspective: assembly line immunotherapy. Nature, 498, 2013, S17.
22. Levine, B., Packer, M., Codogno, P., Development of autophagy inducers in clinical medicine. J. Clin. Invest. 125 (2015), 14–24.
23. Loi, S., Pommey, S., Haibe-Kains, B., Beavis, P.A., Darcy, P.K., Smyth, M.J., Stagg, J., CD73 promotes anthracycline resistance and poor prognosis in triple negative breast cancer. Proc. Natl. Acad. Sci. U S A 110 (2013), 11091–11096.
24. Ma, Y., Adjemian, S., Mattarollo, S.R., Yamazaki, T., Aymeric, L., Yang, H., Portela Catani, J.P., Hannani, D., Duret, H., Steegh, K., et al. Anticancer chemotherapy-induced intratumoral recruitment and differentiation of antigen-presenting cells. Immunity 38 (2013), 729–741.
25. Madeo, F., Pietrocola, F., Eisenberg, T., Kroemer, G., Caloric restriction mimetics: towards a molecular definition. Nat. Rev. Drug Discov. 13 (2014), 727–740.
26. Makarem, N., Chandran, U., Bandera, E.V., Parekh, N., Dietary fat in breast cancer survival. Annu. Rev. Nutr. 33 (2013), 319–348.
27. Marino, G., Pietrocola, F., Eisenberg, T., Kong, Y., Malik, S.A., Andryushkova, A., Schroeder, S., Pendl, T., Harger, A., Niso-Santano, M., et al. Regulation of autophagy by cytosolic acetyl-coenzyme A. Mol. Cell 53 (2014), 710–725.
28. Martins, I., Wang, Y., Michaud, M., Ma, Y., Sukkurwala, A.Q., Shen, S., Kepp, O., Metivier, D., Galluzzi, L., Perfettini, J.L., et al. Molecular mechanisms of ATP secretion during immunogenic cell death. Cell Death Differ. 21 (2014), 79–91.
29. McNally, A., Hill, G.R., Sparwasser, T., Thomas, R., Steptoe, R.J., CD4+CD25+ regulatory T cells control CD8+ T-cell effector differentiation by modulating IL-2 homeostasis. Proc. Natl. Acad. Sci. U S A 108 (2011), 7529–7534.
30. Michaud, M., Martins, I., Sukkurwala, A.Q., Adjemian, S., Ma, Y., Pellegatti, P., Shen, S., Kepp, O., Scoazec, M., Mignot, G., et al. Autophagy-dependent anticancer immune responses induced by chemotherapeutic agents in mice. Science 334 (2011), 1573–1577.
31. Michaud, M., Xie, X., Bravo-San Pedro, J.M., Zitvogel, L., White, E., Kroemer, G., An autophagy-dependent anticancer immune response determines the efficacy of melanoma chemotherapy. Oncoimmunology, 3, 2014, e944047.
32. Mizushima, N., Yamamoto, A., Matsui, M., Yoshimori, T., Ohsumi, Y., In vivo analysis of autophagy in response to nutrient starvation using transgenic mice expressing a fluorescent autophagosome marker. Mol. Biol. Cell 15 (2004), 1101–1111.
33. Mizushima, N., Levine, B., Cuervo, A.M., Klionsky, D.J., Autophagy fights disease through cellular self-digestion. Nature 451 (2008), 1069–1075.
34. Morselli, E., Marino, G., Bennetzen, M.V., Eisenberg, T., Megalou, E., Schroeder, S., Cabrera, S., Benit, P., Rustin, P., Criollo, A., et al. Spermidine and resveratrol induce autophagy by distinct pathways converging on the acetylproteome. J. Cell Biol. 192 (2011), 615–629.
35. Obeid, M., Tesniere, A., Ghiringhelli, F., Fimia, G.M., Apetoh, L., Perfettini, J.L., Castedo, M., Mignot, G., Panaretakis, T., Casares, N., et al. Calreticulin exposure dictates the immunogenicity of cancer cell death. Nat. Med. 13 (2007), 54–61.
36. Onakpoya, I., Hung, S.K., Perry, R., Wider, B., Ernst, E., The use of Garcinia extract (hydroxycitric acid) as a weight loss supplement: a systematic review and meta-analysis of randomised clinical trials. J. Obes., 2011, 2011, 509038.
37. Pellegatti, P., Raffaghello, L., Bianchi, G., Piccardi, F., Pistoia, V., Di Virgilio, F., Increased level of extracellular ATP at tumor sites: in vivo imaging with plasma membrane luciferase. PLoS One, 3, 2008, e2599.
38. Pietrocola, F., Lachkar, S., Enot, D.P., Niso-Santano, M., Bravo-San Pedro, J.M., Sica, V., Izzo, V., Maiuri, M.C., Madeo, F., Marino, G., Kroemer, G., Spermidine induces autophagy by inhibiting the acetyltransferase EP300. Cell Death Differ. 22 (2015), 509–516.
39. Rao, S., Tortola, L., Perlot, T., Wirnsberger, G., Novatchkova, M., Nitsch, R., Sykacek, P., Frank, L., Schramek, D., Komnenovic, V., et al. A dual role for autophagy in a murine model of lung cancer. Nat. Commun., 5, 2014, 3056.
40. Rubinsztein, D.C., Codogno, P., Levine, B., Autophagy modulation as a potential therapeutic target for diverse diseases. Nat. Rev. Drug Discov. 11 (2012), 709–730.
41. Shoji-Kawata, S., Sumpter, R., Leveno, M., Campbell, G.R., Zou, Z., Kinch, L., Wilkins, A.D., Sun, Q., Pallauf, K., MacDuff, D., et al. Identification of a candidate therapeutic autophagy-inducing peptide. Nature 494 (2013), 201–206.
42. Sistigu, A., Yamazaki, T., Vacchelli, E., Chaba, K., Enot, D.P., Adam, J., Vitale, I., Goubar, A., Baracco, E.E., Remedios, C., et al. Cancer cell-autonomous contribution of type I interferon signaling to the efficacy of chemotherapy. Nat. Med. 20 (2014), 1301–1309.
43. Stagg, J., Divisekera, U., Duret, H., Sparwasser, T., Teng, M.W., Darcy, P.K., Smyth, M.J., CD73-deficient mice have increased antitumor immunity and are resistant to experimental metastasis. Cancer Res. 71 (2011), 2892–2900.
44. Strong, R., Miller, R.A., Astle, C.M., Floyd, R.A., Flurkey, K., Hensley, K.L., Javors, M.A., Leeuwenburgh, C., Nelson, J.F., Ongini, E., et al. Nordihydroguaiaretic acid and aspirin increase lifespan of genetically heterogeneous male mice. Aging Cell 7 (2008), 641–650.
45. Sugar, E., Pascoe, A.J., Azad, N., Reporting of preclinical tumor-graft cancer therapeutic studies. Cancer Biol. Ther. 13 (2012), 1262–1268.
46. Tee, M.C., Cao, Y., Warnock, G.L., Hu, F.B., Chavarro, J.E., Effect of bariatric surgery on oncologic outcomes: a systematic review and meta-analysis. Surg. Endosc. 27 (2013), 4449–4456.
47. Teng, M.W., Ngiow, S.F., von Scheidt, B., McLaughlin, N., Sparwasser, T., Smyth, M.J., Conditional regulatory T-cell depletion releases adaptive immunity preventing carcinogenesis and suppressing established tumor growth. Cancer Res. 70 (2010), 7800–7809.
48. Tesniere, A., Schlemmer, F., Boige, V., Kepp, O., Martins, I., Ghiringhelli, F., Aymeric, L., Michaud, M., Apetoh, L., Barault, L., et al. Immunogenic death of colon cancer cells treated with oxaliplatin. Oncogene 29 (2010), 482–491.
49. Uhl, M., Kepp, O., Jusforgues-Saklani, H., Vicencio, J.M., Kroemer, G., Albert, M.L., Autophagy within the antigen donor cell facilitates efficient antigen cross-priming of virus-specific CD8+ T cells. Cell Death Differ. 16 (2009), 991–1005.
50. White, E., The role for autophagy in cancer. J. Clin. Invest. 125 (2015), 42–46.
51. Yamaguchi, T., Hirota, K., Nagahama, K., Ohkawa, K., Takahashi, T., Nomura, T., Sakaguchi, S., Control of immune responses by antigen-specific regulatory T cells expressing the folate receptor. Immunity 27 (2007), 145–159.
52. Zitvogel, L., Galluzzi, L., Smyth, M.J., Kroemer, G., Mechanism of action of conventional and targeted anticancer therapies: reinstating immunosurveillance. Immunity 39 (2013), 74–88.